In Rh hemolytic disease, when does maternal sensitization typically occur?

RRB Nsg. Superintendent -29 April-2025 (shift-2nd)

Obstetrics & Gynaecology

Easy

Appeared in: RRB Nsg. Superintendent -29 April-2025 (shift-2nd)

Explanation

Maternal sensitization (alloimmunization) occurs when an Rh-negative mother is exposed to Rh-positive fetal red blood cells, triggering an immune response.
While the maternal and fetal circulations are largely separate, the most significant mixing of blood typically happens during labor and delivery as the placenta detaches.
This fetomaternal hemorrhage exposes the mother's immune system to fetal Rh antigens, leading to the production of anti-Rh antibodies.
Because this primary immune response takes time to develop, the first Rh-positive infant is usually unaffected. The risk is to subsequent Rh-positive fetuses.

Option B: Significant fetomaternal hemorrhage is very rare during the first trimester of a normal, uncomplicated pregnancy. The placental barrier is effective at preventing blood mixing.
Option C: Similar to the first trimester, the second trimester of a normal pregnancy does not typically involve significant mixing of maternal and fetal blood.
Option D: Although small, clinically silent micro-hemorrhages can occur in the third trimester, the volume of blood is usually insufficient for primary sensitization. The main sensitizing event is delivery.

Visual 1: Diagram: Illustration of an Rh-negative mother and Rh-positive fetus, showing the exchange of fetal red blood cells into the maternal circulation during delivery and the subsequent formation of anti-Rh antibodies.
Visual 2: Flowchart: A flowchart depicting the process of Rh sensitization in the first pregnancy and the mechanism of hemolytic disease in a subsequent pregnancy, highlighting the role of maternal IgG antibodies crossing the placenta.

Clinical Relevance

Nursing practice connection: Knowing Timing of maternal sensitization in Rh hemolytic disease helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
The entire prevention strategy for Rh hemolytic disease is based on understanding this timing. Administering Rho(D) immune globulin (RhoGAM) at 28 weeks and within 72 hours postpartum prevents the mother's immune system from ever 'seeing' the fetal Rh antigen and making antibodies.
A key nursing responsibility is to ensure all Rh-negative mothers are identified early in pregnancy and to manage the administration of RhoGAM at the correct times.
What if? If an Rh-negative mother experiences a miscarriage, ectopic pregnancy, or undergoes amniocentesis at 12 weeks gestation, she must receive RhoGAM at that time. Any event that could cause fetomaternal hemorrhage, regardless of gestational age, is an indication for RhoGAM to prevent sensitization.

How to Approach the Question

First, identify the core concept of the question, which is 'maternal sensitization' in 'Rh hemolytic disease'.
Recall the pathophysiology: Sensitization requires the mixing of Rh-positive fetal blood with Rh-negative maternal blood.
Analyze the options by considering at which point in pregnancy the most significant blood mixing is likely to occur.
Eliminate the trimesters (B, C, D) as the primary time, because in a normal pregnancy, the placenta effectively separates the two circulatory systems. While minor leaks can happen, they are not the 'typical' major sensitizing event.
Identify delivery (A) as the event where placental separation occurs, leading to the most substantial fetomaternal hemorrhage and therefore the most common time for initial sensitization.

Concept Tested & Keywords

QTfq97MS3tH5WDkOxCzBQW